Relora By Pure Encapsulations Overview & Drug Interactions

Check For Interactions With Relora

Supplement: Relora by Pure Encapsulations

Relora Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Relora by Pure Encapsulations

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 180
UPC/BARCODE 766298006840

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Relora Proprietary Patented Blend
250 mg
Proprietary Blend (Herb/Botanical) --
Magnolia (Magnolia officinalis) extract
0 NP
Magnolia
Phellodendron (Phellodendron amurense) extract
0 NP
Phellodendron

Other Ingredients:
Vegetarian Capsule
Forms
  • Cellulose
  • Water
Modified Food and Corn Starch
hypoallergenic Plant Fiber
Forms
  • Cellulose
Ascorbyl Palmitate
Silicon Dioxide


Label Statments:


Storage
- Store sealed in a cool dry area
Formulation
- Commitment to Quality Program Sourced and manufactured to avoid: Artificial additives Allergens GMOs Environmental contaminants Added excipients www.PureEncapsulations.com/QualityControl See Supplement Facts for specific product details
- Promotes satiety and moderates occasional stress
- Hypoallergenic
Suggested/Recommended/Usage/Directions
- Recommendations: As a dietary supplement, take 1 capsule, 3 times daily, with or between meals.
Precautions
- Tamper resistant: use only if safety seal is intact.
- Warning: Not to be taken by pregnant or lactating women. If you have any health condition or are taking any medication, particularly SSRI medications or MAO inhibitors, consult your health professional before use.
- Keep out of the reach of children.
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- Relora is a registered trademark of InterHealth N.I. Relora brand Magnolia officinalis and Phellodendron amurense (U.S. Patents 6582735 and 6814987).
FDA Disclaimer Statement
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Brand Information

See all products by this brand

Manufactured and Formulated by
Name Pure Encapsulations, Inc.
City Sudbury
State MA
Country USA
Phone Number 1-800-753-2277
Web Address www.PureEncapsulations.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.